Nguyen TTA, Postlewait LM, Zhang C, Meisel JL, et al. Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer. Breast Cancer Res Treat 2022 Jan 27. pii: 10.1007/s10549-022-06530.
PMID: 35084624